Navigation Links
Interleukin Genetics Reports Third Quarter 2008 Financial Results
Date:11/13/2008

University offset by a decrease in consulting related expenses.

Selling, general and administrative expenses were $1.6 million for the third quarter of 2008 compared to $1.2 million for the same period last year. The increase is primarily attributable to increased promotional and advertising activities in both the personalized health segment and the consumer products segment, in addition to increased compensation expenses due to increased headcount.

On September 30, 2008, the Company had cash and cash equivalents of $5.9 million compared to $7.6 million of cash and cash equivalents on December 31, 2007. In addition, the Company has access to $10.3 million under credit facilities with Alticor, which permit borrowing until March 31, 2009.

Third Quarter and Recent Highlights

-- Entered into a Research and License Agreement with Geisinger Health System: In September 2008, Interleukin Genetics and Geisinger announced a collaboration permitting Interleukin Genetics to utilize Geisinger's databases to develop a series of genetic tests that will help physicians better understand an individual's inherited resistance to weight loss and gauge a patient's likelihood of success with diet and other weight loss techniques.

-- Revised Exclusive License Agreement with Alticor Corporation's Access Business Group International, LLC (ABG): In September 2008, Interleukin Genetics and ABG amended the companies' existing agreement to expand Interleukin Genetics' distribution network for genetic tests jointly developed by the two companies. The revised agreement permits the Company to sell products through additional channels of its choosing.

-- Licensed PST Genetic Test to OralDNA Labs, Inc.: In August 2008, Interleukin Genetics announced a marketing, sales and distribution agreement for its proprietary PST genetic risk assessment test for use in the diagnosis of periodontal disease. As compensation, the Company will receive a payment from OralDNA
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
2. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
3. Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
4. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
5. Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results
6. Interleukin Genetics to Present at 2008 BIO International Convention
7. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
8. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
9. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
11. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
(Date:7/25/2014)... At the request of the AMA, the ... for the public comment period (Docket No. FAA-2014-0396) for ... established by Congress as part of the FAA Modernization ... the new deadline for comments as September 23, 2014. ... published in the Federal Register on July 25, 2014, ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Gain ... Global Supply Chain of the biotech industry. Nominations ... Innovation Awards, brought to you by the ... organization of supply chain management professionals for the ... to stakeholders of the Biotech industry – Manufacturers, ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6FAA Grants Comment Extension at the Request of AMA 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3
... Wis. - The Potawatomi Business Development Corp. ... Wisconsin information technology firm OneProspect Technologies , and ... ,OneProspect, which had been a business division of the ... the Forest County Potawatomi Community. In January of 2006, ...
... - Since its inception, the Wisconsin Manufacturing Extension ... mid-size manufacturers get lean and mean. Now, the organization ... manufacturers grow, and that includes businesses in the biotechnology ... recently won the Wisconsin's top economic development award, is ...
... technology expenditures of a business. The promise of package ... with a standardized, integrated system, built on processes based ... is combined with promises of a fast implementation and ... package is released. The popularity of package software has ...
Cached Biology Technology:Manufacturing partnership will move into biotech and biomedical spaces 2Manufacturing partnership will move into biotech and biomedical spaces 3Five steps to buying the right package software 2Five steps to buying the right package software 3Five steps to buying the right package software 4Five steps to buying the right package software 5Five steps to buying the right package software 6Five steps to buying the right package software 7
(Date:7/28/2014)... have seen an increase in so-called "nuisance flooding"--which causes ... drains and compromised infrastructure--are on the East Coast, according ... flooding, caused by rising sea levels, has increased on ... since the 1960s. , The report, Sea Level Rise ... also finds Annapolis and Baltimore, Maryland, lead the list ...
(Date:7/28/2014)... bug hunter, but the target of his work consists ... with special methods and instruments. Benjamin Hause, an assistant ... at Kansas State University, recently published an article about ... an important find in the United States. , "We ... what it was," Hause said. "We used next-generation sequencing ...
(Date:7/28/2014)... A powerful new tool that can help advance ... green and renewable bioenergy, has been developed by ... Joint BioEnergy Institute (JBEI), a multi-institutional partnership led ... JBEI researchers have developed an assay that enables ... nucleotide sugar transporters, critical components in the biosynthesis ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3How sweet it is 2How sweet it is 3
... in early childhood significantly contributes to lower performances on ... according to researchers at Duke University and North Carolina ... between lead exposure and test performance, with the effects ... the high end to the low end of the ...
... , PORTOLA VALLEY, Calif., Oct. 19 Spectros, developer ... which shed light on life-threatening diseases, announced today that ... T-Stat® VLS Tissue Oximeter and Sensors. The markets ... Luxembourg (Benelux), Suriname, Italy, France, Spain, Portugal, Poland, Greece, ...
... PASADENA, Calif.Scientists at the California Institute of Technology (Caltech) ... simulate the "visual" experience of a blind person who ... an artificial retina. An artificial retina consists of a ... that directly stimulate retinal nerve cells. It is hoped ...
Cached Biology News:Children's blood lead levels linked to lower test scores 2Spectros Signs New International Distribution Deals 2Caltech scientists create robot surrogate for blind persons in testing visual prostheses 2Caltech scientists create robot surrogate for blind persons in testing visual prostheses 3
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
TAR DNA binding protein...
Blue Standard is 3-cyano-7-hydroxycoumarin....
Biology Products: